Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Anakinra | Case report

Multiple drugs

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Caorsi R, et al. Relapsing macrophage activation syndrome rescued by treatment with MAS825, an anti-il1 and Il-18 monoclonal antibody, in two patients with systemic onset juvenile idiopathic arthritis. Pediatric Rheumatology 21 (Suppl.): Oct 2023. Available from: URL: https://dx.doi.org/10.1186/s12969-023-00879-8 [abstract] Caorsi R, et al. Relapsing macrophage activation syndrome rescued by treatment with MAS825, an anti-il1 and Il-18 monoclonal antibody, in two patients with systemic onset juvenile idiopathic arthritis. Pediatric Rheumatology 21 (Suppl.): Oct 2023. Available from: URL: https://dx.doi.org/10.1186/s12969-023-00879-8 [abstract]
Metadata
Title
Multiple drugs
Lack of efficacy
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57723-2

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Risankizumab

Case report

Gilteritinib

Case report

Milrinone